MSD And Sinopharm Unveil Expansion Plans

BMI View: Vietnam's US$1.7bn pharmaceutical market has a classic risk/reward profile. Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase by 17.2% in 2011. Although this figure is below the 20.2% recorded in 2010, it is the second highest expected in Asia this year (behind China (+17.3%), but ahead of Bangladesh (+16.4%)). Other attractions include a growing population and a relatively stable political regime. The key downsides are low annual per-capita pharmaceutical spending, limited urbanisation and unenforced regulations.

To read the full article, please choose one of the following options: